ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ALXO ALX Oncology Holdings Inc

16.46
-0.16 (-0.96%)
最終更新日: 03:01:17
15分遅延
名称 銘柄コード 市場 種別
ALX Oncology Holdings Inc ALXO NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.16 -0.96% 16.46 03:01:17
始値 安値 高値 終値 前日終値
16.92 16.41 17.13 16.62
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/3022:00GLOBEALX Oncology Announces Initiation of Phase 2..
2024/4/2423:00GLOBEALX Oncology Announces Two Evorpacept Abstracts Accepted for..
2024/4/1006:30GLOBEALX Oncology Reports Encouraging Clinical Data of Evorpacept..
2024/3/0806:05EDGAR2Form 8-K - Current report
2024/3/0806:03GLOBEALX Oncology Reports Fourth Quarter and Full Year 2023..
2024/3/0606:30GLOBEALX Oncology Announces Two Evorpacept Clinical Abstracts..
2024/2/1708:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1708:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1708:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0606:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0406:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0406:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0406:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0322:00GLOBEALX Oncology to Present at the 42nd Annual J.P. Morgan..
2023/12/2706:01EDGAR2Form 8-K - Current report
2023/11/1406:05GLOBEALX Oncology Reports Third Quarter 2023 Financial Results..
2023/11/1406:03EDGAR2Form 8-K - Current report
2023/11/0205:05GLOBEALX Oncology Announces November Investor Conference..
2023/10/1105:05GLOBEALX Oncology Announces Closing of Public Offering, Including..
2023/10/0619:06EDGAR2Form 8-K - Current report
2023/10/0619:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/10/0521:00GLOBEALX Oncology Announces Pricing of Public Offering
2023/10/0506:21EDGAR2Form 8-K - Current report
2023/10/0506:21EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/10/0505:10GLOBEALX Oncology Announces Proposed Public Offering
2023/10/0421:00EDGAR2Form 8-K - Current report
2023/10/0323:03IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Recommendations
2023/10/0319:00GLOBEALX Oncology Reports Positive Interim Phase 2 ASPEN-06..
2023/10/0305:05GLOBEALX Oncology to Host Investor Call and Webcast on October 3,..
2023/9/2021:45IHNWPathways to Progress: How Orphan Drug Designation Sparks..
2023/9/1113:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/9/0905:25EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/9/0705:05EDGAR2Form 8-K - Current report
2023/9/0621:00GLOBEALX Oncology Realigns Executive Leadership Team
2023/9/0205:11EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/8/3120:00GLOBEALX Oncology Announces September Investor Conference..
2023/8/2605:44EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/8/1105:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1105:05EDGAR2Form 8-K - Current report
2023/8/1105:01GLOBEALX Oncology Reports Second Quarter 2023 Financial Results..
2023/7/2805:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/2805:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/2805:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/0805:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/0606:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/0606:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/0606:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/6/2620:00GLOBEALX Oncology Receives Orphan Drug Designation from the..
2023/5/1205:01GLOBEALX Oncology Reports First Quarter 2023 Financial Results..
2023/5/0920:00GLOBEALX Oncology Announces First Patient Dosed in Phase 2..

最近閲覧した銘柄

Delayed Upgrade Clock